DFRF4539A Naked Antibody: A Novel Therapeutic Agent
The innovative therapeutic therapy, DFRF4539A, represents the promising bare immunoglobulin. This distinctive molecule rapidly targets malignant cells lacking any need for traditional medication administration methods. Early findings indicate significant effectiveness at managing multiple disease